SYNAPSET
Live / Registered — Registered — Section 8 accepted (as of 16 Jun 2025)
What this means for you
Registered since 11 Sept 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Sept 2028: the §8 & §9 renewal).
Record
- Serial number
- 87431283
- Registration number
- 5558464
- Mark type
- Word mark
- Filed
- 30 Apr 2017
- Published for opposition
- 26 Jun 2018
- Registered
- 11 Sept 2018
- Next maintenance filing
- §8 & §9 renewal, due by 11 Sept 2028 (grace period to 11 Mar 2029)
- Attorney of record
- Jess M. Collen
Goods and services
- Class 005 — Pharmaceuticals: [ Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; ] Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; ] Dietary [ and nutritional ] supplements containing fish oils, minerals, vitamins [ , plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements also containing minerals, vitamins, oils; Dietary supplements for human consumption ] ; Dietary supplements for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods for treating attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Edible fish oils, mineral preparations, vitamins, and medicinal plant oils adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of pharmaceutical preparations; Edible fish oils for medical purposes; Food supplements; Food supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Gummy vitamins; Liquid nutritional supplement; Liquid vitamin supplements; Medicaments for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson 's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicated water for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicinal drinks; Migraine treatment preparations; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations ] ; Multivitamin preparations; [ Natural dietary supplements; Natural dietary supplements for the treatment of attentiondeficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Natural supplements for treating depression and anxiety; Nutraceuticals for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutraceuticals for use as a dietary supplement; ] Nutraceuticals for use as a dietary supplement for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement shakes; Nutritional supplements ] ; Nutritional supplements consisting primarily of Omega3 oil, vitamins, vitamin B6, minerals, zinc, magnesium [ ; Nutritional supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional supplements in the form of powder, liquid, capsules, tablets, gel; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment and prevention of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for treating chemical imbalances; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing fish oils, vitamins, minerals, plant oils; Therapeutic pharmaceutical for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin and mineral supplements for mixing with food and beverages; Vitamin B preparations; Vitamin fortified beverages for medical purposes; Vitamin preparations; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations ]
Owner
- Bioflash inc, Sherbrooke, CA
- Bioflash inc, Sherbrooke, CA
- Bioflash inc, Sherbrooke, CA
Board proceedings on this mark
- Cancellation No. 92069619 — Akyron Industries Incorporated v. Bioflash inc, filed 20 Sept 2018 (Terminated)
Prosecution history
- 02 Nov 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Nov 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 02 Nov 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Nov 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 16 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 16 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Mar 2025 — TEAS SECTION 8 RECEIVED
- 11 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Aug 2019 — TTAB RELEASE CASE TO TRADEMARKS
- 20 Aug 2019 — CANCELLATION TERMINATED NO. 999999
- 20 Aug 2019 — CANCELLATION DENIED NO. 999999
- 01 Oct 2018 — CANCELLATION INSTITUTED NO. 999999
- 11 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 26 Jun 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED